Shanghai Jikai Gene Medical Technology Co., Ltd.
PrivateLast Round
Series D
Jul 30, 2020
Est. Valuation
$428.57M
Total Funding Raised
$100.31M
Company Overview
Shanghai Jikai Gene Medical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series D round in July 2020.
Shanghai Jikai Gene Medical Technology Co., Ltd. is a biotechnology company that provides a platform for target discovery and validation, development of antibody and cell therapy products, and related technical services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Jikai Gene Medical Technology Co., Ltd. Comparables
Compare Shanghai Jikai Gene Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Suzhou GenePharma Co., Ltd. | 84% | |
| VectorBuilder | 81% | |
| OBiO Technology | 80% |
For institutional investors. Book with your work email.
Shanghai Jikai Gene Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 30, 2020 | ||||
| Series C | Mar 25, 2020 | ||||
| Series C | Mar 1, 2019 | ||||
| Early Funding | Jan 1, 2019 | ||||
| Series B | Jan 5, 2016 | ||||
Series A | Dec 1, 2014 |
For institutional investors. Book with your work email.
Shanghai Jikai Gene Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| InnoSpring | Series C |
| Huasheng Capital | Series B |
| NewMargin Ventures | Series C |
| Principle Capital (China) | Series B |
| Shanghai Free Trade Zone Fund | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2020
Raised $29M with Suzhou Zelgen Biopharmaceuticals and Wang Yongsheng participating.
- Apr 2, 2020
$57M round with participation from NewMargin Ventures and zhejiang-zhuji-lianchuang-yongjun-medical-device-fund.
For institutional investors. Book with your work email.
Shanghai Jikai Gene Medical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Jikai Gene Medical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Jikai Gene Medical Technology Co., Ltd. a public or private company?
Shanghai Jikai Gene Medical Technology Co., Ltd. is a private company.
What is the current stock price of Shanghai Jikai Gene Medical Technology Co., Ltd.?
Shanghai Jikai Gene Medical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Jikai Gene Medical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Jikai Gene Medical Technology Co., Ltd. worth (valuation)?
Shanghai Jikai Gene Medical Technology Co., Ltd.'s valuation is estimated at $428.6M based on funding round data.
Can I buy Shanghai Jikai Gene Medical Technology Co., Ltd. stock?
Shanghai Jikai Gene Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Jikai Gene Medical Technology Co., Ltd.'s last funding round?
Shanghai Jikai Gene Medical Technology Co., Ltd.'s most recent funding round was Series D on July 30, 2020.
Who are the main investors in Shanghai Jikai Gene Medical Technology Co., Ltd.?
Key investors in Shanghai Jikai Gene Medical Technology Co., Ltd. include HighLight Capital, InnoSpring, Huasheng Capital, NewMargin Ventures, Principle Capital (China).
Will Shanghai Jikai Gene Medical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Jikai Gene Medical Technology Co., Ltd..
How can I track Shanghai Jikai Gene Medical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Jikai Gene Medical Technology Co., Ltd.'s shares on secondary markets.